Drug Trial Radar · NCT05348200
Safety and Efficacy of CITI-002 in Adult Patients With Moderate Grade Hemorrhoids
Last checked: Nov 20, 2026Latest source record: Aug 31, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
304
Actual
Start
Apr 22, 2022
Primary completion
Apr 20, 2023
Study completion May 17, 2023
Sponsor
- Lead sponsor
- Citius Pharmaceuticals, Inc.Industry
- Sponsor type
- Industry
- Collaborators
- Therapeutics, Inc.
- First posted
- Apr 27, 2022
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A Randomized Phase 2 double blind study which aims to determine the safety and efficacy of CITI-002 cream in adult patients with Goligher's grade II or III hemorrhoids.
Conditions
- Hemorrhoids
Interventions
Monad 1Drug
Single therapy cream containing Lidocaine. Lidocaine is a topical anesthetic.
Monad 2Drug
Single therapy cream containing Halobetasol Propionate (low-strength). HPB is a topical corticosteroid.
Monad 3Drug
Single therapy cream containing Halobetasol Propionate (high strength).
Combination - CITI-002 (low dose)Drug
Combination cream containing Lidocaine and HBP (low)
Combination - CITI-002 (high dose)Drug
Combination cream containing Lidocaine and HBP (high)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in Hemorrhoid symptomsTime frame: Day 8
Locations
16 sites in 1 country. Site status is shown where the registry gives one.
Site #01
Huntsville, Alabama
Site #07
Tucson, Arizona
Site #06
Chula Vista, California
Site #09
Pomona, California
Site #16
San Diego, California
Site #03
San Diego, California
Site #05
West Palm Beach, Florida
Site #10
Covington, Louisiana
Site #12
Prairieville, Louisiana
Site #02
Wyoming, Michigan
Site #14
Gulfport, Mississippi
Site #08
Omaha, Nebraska
Site #11
Mentor, Ohio
Site #13
Tulsa, Oklahoma
Site #04
Harrisburg, Pennsylvania
Site #15
McKinney, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.